X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-07-16 | SE | Sea Ltd | Ye Gang | COO | S - Sale | $105.61 | -40,000 | 21,956,405 | 0% | -$4,224,277 | |||||
| M | 2026-07-16 | ECAT | Blackrock Esg Capital Allocation Term Trust | Saba Capital Management, L.P. | 10% | S - Sale | $15.43 | -115,941 | 16,951,009 | -1% | -$1,788,565 | |||||
2026-06-17 | TM | Toyota Motor Corp/ | Sato Koji | Vice COB | S - Sale | $17.83 | -88,600 | 578,810 | -13% | -$1,579,738 | ||||||
2026-07-17 | SE | Sea Ltd | Hou Tianyu | CFO | S - Sale | $103.26 | -15,000 | 2,428,015 | -1% | -$1,548,943 | ||||||
| M | 2026-07-15 | MPLT | Maplight Therapeutics, Inc. | Gillis Jonathan | CAO, Interim CFO | S - Sale | $37.12 | -36,979 | 144,240 | -20% | -$1,372,668 | |||||
| M | 2026-07-15 | MPLT | Maplight Therapeutics, Inc. | Kreitzer Anatol | Chief Discovery Officer | S - Sale | $37.09 | -36,284 | 174,906 | -17% | -$1,345,894 | |||||
| D | 2026-07-17 | GLBE | Global-E Online Ltd. | Tamari Shahar | COO | S - Sale+OE | $37.98 | -24,999 | 3,906,687 | -1% | -$949,500 | |||||
2026-07-16 | NEXN | Nexxen International Ltd. | Niri Sagi | CFO | S - Sale | $10.31 | -35,000 | 144,066 | -20% | -$360,976 | ||||||
2026-07-15 | MLTX | Moonlake Immunotherapeutics | Reich Kristian | Chief Scientific Officer | S - Sale | $20.01 | -16,105 | 2,843,835 | -1% | -$322,261 | ||||||
| M | 2026-07-16 | SE | Sea Ltd | Wang Yanjun | CCO, GC | S - Sale | $106.05 | -2,700 | 1,193,742 | 0% | -$286,327 | |||||
| D | 2026-07-15 | DOCS | Doximity, Inc. | Sitaram Siddharth | Chief Accounting Officer | S - Sale+OE | $22.02 | -1,732 | 93,774 | -2% | -$38,139 | |||||
2026-07-15 | FRMM | Forum Markets Inc | Lomashuk Konstantin | 10% | S - Sale | $6.30 | -2,562 | 1,476,638 | 0% | -$16,141 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |